Thursday, May 16, 2019 8:41:13 AM
"("Kontrol" or "Company") is pleased to announce that its leading emission compliance operating subsidiary, ORTECH Consulting Inc. ("ORTECH"), has received a $565,000 order from a global cement company. The order is for emission compliance services for the 2019 year.
"This represents a significant increase in services to an existing customer that includes annual recurring revenue for ORTECH," said Paul Ghezzi, CEO Kontrol Energy. "Expanding our services and technology solutions within our existing customer base is an area of strategic focus for the Company. This organic growth further demonstrates to the market that Kontrol offers its clients an exceptional suite of services to help optimize their operations."
For industry competitive purposes the global cement company will not be disclosed.
"We see additional opportunities, as part of our Smart Factory strategic partnership with Toyota Tsusho, announced on March 25th, 2019. We anticipate robust growth in our emission compliance and measurement revenues as the customer Factory portfolio is expanded," continued Paul Ghezzi.
According to MarketsandMarkets Research, the emission monitoring systems market is estimated to reach US $4.44 Billion by 2025 from US $2.39 Billion in 2018, at a CAGR of 9.3% between 2018 and 2025. Factors that are driving the emission monitoring systems market include stringent legal and environmental regulations, increased awareness about environmental protection, increasing health and safety issues, and growing use of oil & gas and petrochemicals. www.marketsandmarkets.com
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM